Skip to main content
. 2024 May 24;15(2):92791. doi: 10.4291/wjgp.v15.i2.92791

Figure 4.

Figure 4

Estimated prevalence of metabolic dysfunction-associated steatotic liver disease subtypes. MASLD: Metabolic dysfunction-associated Steatotic liver disease, US: Ultrasound: DM: Diabetes mellitus; BMI: Body mass index.